Clinical Trials
2 trialsNCT06726369 2026-05-07
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT03723291 2026-03-03
PITSTOP
University College, London
Phase 1 Completed